LeBleu® and KAMIYA Make Debut in Hong Kong, Drawing Widespread Industry Attention
HONG KONG, Nov. 13, 2026 /PRNewswire/ -- Eyebright Medical Technology (Beijing) Co., Ltd. (referred to as "Eyebright Medical", Stock Code: 688050.SH) completed its participation in the Hong Kong International Optical Fair 2026. Held from November 4 to 6, 2026, at the Hong Kong Convention and Exhibition Centre, the fair serves as a trade event for the optometry and eyewear industry, bringing together global buyers, eye care professionals, and brand representatives as a platform for technology exchange and international channel expansion.
At this year's exhibition, Eyebright Medical presented its vision care brand portfolio. Driven by the steady growth of the group's vision care sector, the dual brands LeBleu® and KAMIYA made a simultaneous appearance, showcasing Eyebright Medical's end-to-end R&D, manufacturing, and sales capabilities to partners across the Asia-Pacific region.
As Eyebright Medical's representative brand for contact lenses, LeBleu® incorporates the group's R&D capabilities in optical design and manufacturing. Backed by Eyebright Medical's R&D team of over 300 professionals and two self-owned, GMP-certified smart manufacturing bases — Jiangsu Tianyan Medical and Fujian Evercon, with a combined standardized R&D and production space of over 120,000 square meters. LeBleu® maintains end-to-end control over material R&D, optical design, manufacturing, and quality control, safeguarding product stability and wearing safety at the source.
LeBleu® presented several product series at the fair, including silicone hydrogel series, EDF aspheric daily disposable contact lenses, EDF+ high-order aspheric bi-weekly and half-year disposable contact lenses, and Toric color contact lenses. The product line incorporates Extended Depth of Focus (EDF) aspheric optical design alongside storage solution formulations containing Vitamin B12 and Hyaluronic Acid tailored for daily wear.
Sharing the spotlight was KAMIYA, an emerging color contact lens brand, which showcased its Spotlight Series Toric Color Contact Lenses in their Hong Kong debut. As Eyebright Medical's brand in the color lens segment, KAMIYA focuses on consumer preferences for fashion aesthetics and product value. Supported by Eyebright Medical's manufacturing infrastructure and digital quality control, KAMIYA maintains batch-level product traceability. Furthermore, utilizing high-speed AOI optical inspection systems and supply chain management, KAMIYA optimizes its cost structure to deliver accessible pricing.
The sample trial sessions during the exhibition generated strong interest. Channel partners from Hong Kong, Macao, and Southeast Asia inquired about product registration, packaging localization, and market promotion strategies, evaluating the commercial potential of color lens brands among young Asia-Pacific consumers.
Eyebright Medical's participation attracted media coverage and on-site interviews. Mr. Jia Baoshan, Deputy General Manager and Sales and Market Sales Director of Eyebright Medical Technology (Beijing) Co., Ltd., together with Ms. Zhou Yuxi, General Manager of Eyebright Medical's Hong Kong subsidiary, jointly participated in media interviews and shared the group's operational developments, outlining Eyebright Medical's international growth orientation and overall business structure. The organizer, Hong Kong Trade Development Council, also highlighted Eyebright Medical as an exhibitor case study across official event communications.
As an international hub connecting Mainland China with global markets, Hong Kong serves as a strategic node for Eyebright Medical's regional roadmap. Leveraging Hong Kong's business network and regulatory framework, Eyebright Medical's local team continues to advance international registration, academic engagement, and channel development across its vision care and ophthalmic device portfolios.
About Eyebright Medical Technology (Beijing) Co., Ltd.
Eyebright Medical Technology (Beijing) Co., Ltd. is listed on the STAR Market of the Shanghai Stock Exchange (Stock Abbreviation: Eyebright Medical, Stock Code: 688050.SH). Located in Zhongguancun Science Park, Beijing, it is a National High-Tech Enterprise and a recognized National "Little Giant" Enterprise specializing in niche markets. As an innovation-driven high-end medical device manufacturer with a global vision, Eyebright Medical has strategically laid out its presence across four high-potential sectors: ophthalmic surgical treatments, myopia management, consumer vision care, and sports medicine. Leveraging deep technical barriers and robust commercialization capabilities, the company is positioning itself among global medical technology leaders as a representative of China's intelligent manufacturing strength.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Eyebright Medical Successfully Concludes Participation in Hong Kong International Optical Fair 2026
Eyebright Medical Successfully Concludes Participation in Hong Kong International Optical Fair 2026
New 7,200+ sq ft Singapore facility brings together global expertise to turn ideas into solutions for more than 40 Asia Pacific markets and beyond, with plans to create over 250 specialist roles by 2029.
SINGAPORE, Nov. 13, 2026 /PRNewswire/ -- Mastercard today opened its largest Innovation Centre of Excellence (ICoE) in Asia Pacific, creating a new regional hub where financial institutions, merchants, governments and technology partners can work alongside Mastercard specialists to shape the future of commerce in the intelligence economy.
The 7,200+ sq ft facility brings together expertise in AI, cybersecurity, customer experience and rapid prototyping, turning promising ideas into real-world solutions faster. More than 55 specialists are already working across the ICoE to help partners address emerging challenges, strengthen resilience and create better digital experiences.
Mastercard plans to add over 250 specialist roles in Singapore by the end of 2029, expanding the talent and capabilities needed to advance responsible AI, trusted digital commerce, cybersecurity, data and payments across the region.
"Mastercard's Innovation Centre of Excellence brings together banks, merchants, technology companies and governments to develop and test new solutions. By combining expertise in AI, cybersecurity and fraud intelligence, it will help turn emerging technologies into solutions that businesses and consumers can trust," said Dr Tan See Leng, Minister for Energy, Trade and Industry (Energy and Industry), Singapore, at the launch. "I hope the ICoE will become a lighthouse for payments innovation in Asia Pacific, where new solutions are developed and proven in Singapore, before being adapted and deployed across ASEAN, India and beyond."
"Mastercard's Innovation Centre of Excellence marks a new chapter in our long-standing and multi-faceted partnership. By deepening its capabilities in AI, cybersecurity and threat intelligence, Mastercard will tackle emerging challenges and seize new opportunities across Asia Pacific. Singapore will continue to be a key hub where companies like Mastercard can innovate and pioneer the next generation of technologies for global markets, and create high-value jobs for Singaporeans," said Png Cheong Boon, Chairman, Singapore Economic Development Board (EDB).
Bringing together the capabilities to build what's next
Designed to evolve with changing technologies, risks and business models, the ICoE brings four complementary spaces together in one facility:
- AI Centre of Excellence: advancing responsible AI solutions that can make commerce safer, smarter and more intuitive, including applications in agentic commerce, fraud and scam prevention.
- Fusion Centre: bringing together expertise across cyber, fraud and physical security to identify emerging risks, coordinate response efforts and strengthen resilience across the ecosystem.
- Mastercard Experience Centre: giving financial institutions, merchants and public sector partners an immersive way to explore emerging technologies and new possibilities for their businesses.
- Makerspace: providing a hands-on environment to rapidly prototype, test and refine ideas, shortening the journey from concept to reality.
"Singapore continues to distinguish itself through its ambition, talent and ability to stay ahead of change. Mastercard has been proud to grow its presence here. This new investment reflects our confidence in Singapore's future and Mastercard's commitment to being a partner for the long term," said Jon Huntsman, Vice Chairman and President, Strategic Growth, Mastercard.
"Asia Pacific is moving quickly into a more intelligent and interconnected economy. The opportunity is to turn new technology into real-world value, securely and at scale," said Richard Wormald, President, Asia Pacific, Mastercard. "The ICoE builds on Mastercard's longstanding collaboration with EDB and Singapore's strength as a proven testbed for innovation. It unites capabilities that traditionally sat apart, supporting the region in tackling shared challenges and moving promising ideas into practice faster."
From Singapore, shaping the future of commerce across Asia Pacific
The opening of ICoE in Singapore comes as businesses across Asia Pacific look to close the gap between technology experimentation and adoption. By 2030, more than one in 10 online shoppers are projected to routinely use AI agents to make purchases on their behalf, while US$3 trillion to US$5 trillion in global consumer commerce could be influenced or orchestrated by agentic AI. Realizing this opportunity will require businesses to deploy new technologies responsibly, with security, governance and human oversight built in from the outset, particularly in a region where cybercrime already accounts for over 30% of recorded crime.
The ICoE will connect Mastercard expertise and insights across more than 40 Asia Pacific markets. From Singapore, it will develop solutions for the region's diverse needs, with the potential for the strongest ideas to scale globally.
Mastercard has more than 850 employees in Singapore, home to its Asia Pacific headquarters and a key market support centre for the region, with the workforce expected to exceed 1,000 by the end of 2029. This growth will deepen the expertise needed to shape a more intelligent, connected and secure future for commerce.
Download high-resolution visuals and supporting materials of the ICoE in Singapore here.
About Mastercard
Mastercard powers economies and empowers people in 200+ countries and territories worldwide. Together with our customers, we're building a resilient economy where everyone can prosper. We support a wide range of digital payments choices, making transactions secure, simple, smart and accessible. Our technology and innovation, partnerships and networks combine to deliver a unique set of products and services that help people, businesses and governments realize their greatest potential.
www.mastercard.com
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Mastercard opens its largest Innovation Centre of Excellence in Asia Pacific to drive the intelligence economy
